(Q48671891)

14 February 2018

title

MRI--the perfect surrogate marker for multiple sclerosis? (English)

1 reference

14 February 2018

0 references

1

Frederik Barkhof

1 reference

14 February 2018

Massimo Filippi

2

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 April 2009

1 reference

14 February 2018

published in

Nature Reviews Neurology

1 reference

14 February 2018

volume

5

1 reference

14 February 2018

issue

4

1 reference

14 February 2018

page(s)

182-183

1 reference

14 February 2018

https://scigraph.springernature.com/pub.10.1038/nrneurol.2009.31

exact match

0 references

cites work

Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.31

Concurrent validity of the MS Functional Composite using MRI as a biological disease marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.31

Eight-year follow-up study of brain atrophy in patients with MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.31

The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.31

Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.31

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.31

Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.31

MRI as an outcome in multiple sclerosis clinical trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.31

Pooled historical MRI data as a basis for research in multiple sclerosis--a statistical evaluation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.31

Disability as an outcome in MS clinical trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.31

Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.31

MRI in multiple sclerosis: current status and future prospects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.31

Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19347020

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRNEUROL.2009.31

1 reference

14 February 2018

PubMed ID

19347020

1 reference

14 February 2018